Novartis’ Promacta bags FDA approval for first-line severe aplastic anemia
Promacta FDA approval : The US Food and Drug Administration (FDA) has approved a label expansion for Novartis’ Promacta (eltrombopag)
Continue readingCoverage of Global Pharma Industry News
Promacta FDA approval : The US Food and Drug Administration (FDA) has approved a label expansion for Novartis’ Promacta (eltrombopag)
Continue readingSwiss pharma giant Novartis has signed a deal valued at about $2.1 billion to acquire US biopharma company Endocyte in
Continue readingNovartis has secured approval from the European Commission (EC) for its skin cancer drug combo Tafinlar (dabrafenib) and Mekinist (trametinib)
Continue reading